6 Local Residents Appointed to Community Group for National Emerging Infectious Diseases Laboratories at BU Medical Center
Contact: Gina M. Digravio, 617-638-8491 | firstname.lastname@example.org
(Boston) – Six members have been appointed the Community Liaison Committee (CLC) of the National Emerging Infectious Diseases Laboratories (NEIDL), BUMC officials announced today.
Three members were appointed by Karen Antman, Dean, Boston University School of Medicine and Provost, Boston University Medical Campus: Dolly Battle, Roxbury; Christopher Brayton, South End; Sheila Grove, South End
Three members were appointed by Elaine Ullian, President and CEO, Boston Medical Center: Glen Berkowitz, South End; Sandra Silver, South End; Michael Kozu, Roslindale.
The participation of the community is important to the success of the NEIDL. In response to the input received during the more than 240 meetings leading to the approval of the NEIDL, BUMC pledged to expand access to information about the laboratory and facilitate an information exchange through the creation of the CLC.
“The CLC will serve as an important outreach and feedback mechanism to facilitate communication and information flow between the NEIDL and the community and to ensure transparency in the activities of the Biosafety Laboratory,” said Mark Klempner, Principal Investigator of the NEIDL.
The members of the CLC will share and distribute information to the community about the projects and activities of the NEIDL; will assist the NEIDL leadership to ensure effective communication and collaboration on programs and activities involving the NEIDL and the community; advise the NEIDL executive committee on potential issues of concern involving the Biosafety Lab and the community and assist the ENEIDL Executive Committee with development and planning of activities to promote collaboration, cooperation and information exchange between the NEIDL and the community.
The CLC will meet quarterly and members will serve 2 year terms.
Members for the CLC were solicited through self nominations Advertisements were placed in local newspapers, on the lab’s website and information was distributed through local neighborhood organizations.
The NEIDL is part of a national network of secure facilities that study infectious diseases—whether they occur naturally or are introduced through bioterrorism. The mission of the NEIDL is to establish a research facility with the highest attention to community and laboratory safety and security to perform cutting-edge research and develop diagnostic tests, treatments and vaccines to promote public health through combating infectious diseases.